Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Botanix Pharmaceuticals Limited ABN: Financial year ended: 70 009 109 755 30 June...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Botanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Notification regarding unquoted securities - BOT
- Application for quotation of securities - BOT
- Notification of cessation of securities - BOT
- Botanix Quarterly Activities Report and Appendix 4C Q4 FY26
- Notice of Allowance for US patent on Sofdra drug substance
Later from Botanix Pharmaceuticals
- Appendix 4E & Annual Report for the Year Ended 30 June 2026
- Change of Director's Interest Notice
- S&P DJI Announces September 2026 Quarterly Rebalance
- 2026 Annual General Meeting - Key Dates
- Board Renewal
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals